IASLC > International Association for the Study of Lung Cancer > Conferences & Events > Event Details
NSCLC Pathology and Molecular Testing- What Should Clinicians Know?
October 10, 2017 | Online


Classification of NSCLC has been rapidly evolving, owing in large part to increased attention to histologic features and common molecular alterations.  This program will review the key terminology in NSCLC pathology and discuss some of the logistical and technical elements of molecular testing that are important for incorporating molecular findings into clinical practice.

What you should expect to learn

After viewing this program attendees will be able to:

  • Identify and define key terms in the pathology of non-small cell lung cancer, and
  • Discuss the importance of multi-disciplinary communication in optimizing tissue management for molecular studies.

Dara L. Aisner, MD, PhD

Associate Professor,
University of Colorado Department of Pathology
Director, Colorado Molecular Correlates Laboratory


Ramaswamy Govindan, MD - Program Chair
Director, Section of Medical Oncology
Professor of Medicine
Anheuser-Busch Endowed Chair in Medical Oncology
Director, Section of Oncology

Washington University School of Medicine